Lykan Bioscience Welcomes Keith McCormick as Chief Financial Officer
Lykan Bioscience Welcomes Keith McCormick as Chief Financial Officer News provided by Share this article Share this article HOPKINTON, Mass., Feb. 15, 2021 /PRNewswire/ -- Lykan Bioscience, a contract Manufacturing Services Organization™ (MSO) and provider of the first true end-to-end solution for the manufacture of cell-based therapies, welcomes Keith McCormick as Chief Financial Officer. Keith brings more than 30 years of finance experience with leadership positions in several leading companies across a range of industries, geographies, and financial disciplines. As CFO, Keith is respo...